Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
WRN - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
BCL2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SMARCB1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HIVEP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
B4GALT5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SYNE2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FN1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PLAGL1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GOLGA8A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
BLVRA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZBTB21 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AGPAT3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CCNE2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
STXBP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UPF3A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DPYSL2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DYRK2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ESR1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on